Dr. Tran BioSci: MannKind Corporation

Showing posts with label MannKind Corporation. Show all posts

Sunday, October 15, 2017

MannKind Corporation: Can Afrezza Improved Labeling Fuel A Successful Comeback?

To learn more how Dr. Tran BioSci can serve your specific needs ...

If you enjoy reading our research, be sure to sign up for our mailing list at Dr. Tran BioSci to get the latest market outperforming insights.

To access the complete article, please go to the premier investing research platform Seeking Alpha.

Mentioned Companies (Incomplete List)

Agenus Inc (AGEN)
Aimmune Therapeutics (AIMT)
Alpine Immune Sciences (ALPN)
Amarin Corporation (AMRN)
Amicus Therapeutics (FOLD)
Arena Pharmaceuticals (ARNA)
Atara Biotherapeutics (ATRA)
Avalon Globocare (AVCO)
Bluebird Bio (BLUE)
Corium International (CORI)
CryoPort Inc (CYRX)
Crispr Therapeutics (CRSP)
CytomX Therapeutics (CTMX)
Enanta Pharmaceuticals (ENTA)
Exelixis, Inc. (EXEL)
Fonar Corporation (FONR)
Galectin Therapeutics (GALT)
Gilead Sciences (GILD)
Global Blood Therapeutics (GBT)
GNC Holdings (GNC)
Herbalife Ltd. (HLF)
Intercept Pharmaceuticals (ICPT)
InterMune, Inc. (ITMN)
Jazz Pharmaceuticals (JAZZ)
Kite Pharma Inc (KITE)
Mallinckrodt (MNK)
MannKind Corporation (MNKD)
Natural Health Trends Corp (NHTC)
Nektar Therapeutics (NKTR)
Neurocrine Biosciences (NBIX)
Nu Skin Enterprises (NUS)
Ocular Therapeuix (OCUL)
Omeros Corporation (OMER)
Orexigen Therapeutics (OREX)
Pharmacyclics, Inc. (PCYC)
Portola Pharmaceuticals (PTLA)
Protalix BioTherapeutics (PLX)
Regeneron Pharmaceuticals (REGN)
Sarepta Therapeutics (SRPT)
Solid Biosciences (SLDB)
Spark Therapeutics (ONcE)
Spectrum Pharmaceuticals (SPPI)
Usana Health Sciences (USNA)
Vanda Pharmaceuticals (VNDA)
Versartis Inc (VSAR)
Vivus, Inc (VVUS)

Dropdown menu

Sunday, October 15, 2017

MannKind Corporation: Can Afrezza Improved Labeling Fuel A Successful Comeback?

To learn more how Dr. Tran BioSci can serve your specific needs ...

If you enjoy reading our research, be sure to sign up for our mailing list at Dr. Tran BioSci to get the latest market outperforming insights. To access the complete article, please go to the premier investing research platform Seeking Alpha.

If you enjoy reading our research, be sure to sign up for our mailing list at Dr. Tran BioSci to get the latest market outperforming insights.

To access the complete article, please go to the premier investing research platform Seeking Alpha.